Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN68,8368,85-0,35
Msft0,20
Nokia4,374,50,25
IBM1,48
Mercedes-Benz Group AG53,8253,841,18
PFE-1,36
06.05.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 05.05.2025
Cormay PZ (CRM.WA, Warsaw)
Závěr k 5.5.2025 Změna (%) Změna (PLN) Objem obchodů (PLN)
0,57 -1,38 -0,01 22 586
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: PZ Cormay SA is a Polish-based producer and wholesaler of diagnostic reagents and a distributor of the laboratory equipment. The Company is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. It offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.
Financial Summary: BRIEF: For the nine months ended 30 September 2024, PZ Cormay SA revenues increased 8% to PLN67M. Net loss increased 52% to PLN5.3M. Revenues reflect Poland segment increase of 31% to PLN16.6M, Switzerland segment increase from PLN0K to PLN1.5M, Ukraine segment increase of 43% to PLN3.1M. Higher net loss reflects reagents and diagnostic equipment segment loss increase of 2% to PLN3.4M.



  • Poslední aktualizace:
Management společnosti
Data nejsou k dispozici